Indicaid COVID-19 (POC)Antigen Rapid Test CovidCLIA license Required to purchase this product Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U. S. C. 263a, that meet the requirements to perform moderate complexity, high complexity, or waived tests. This test is authorized for use at the Point of Care (POC), i. e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of
This test is authorized for use at the Point of Care (POC)
• 6-panel drug screening in a single integrated dip card• Screens for AMP (amphetamines
• Specimen validity/adulteration checks help assess sample integrity and reduce tampering risk (including pH
NEGATIVE TEST RESULT
K2 (spice) and TRA (tramadol)
The DOA® ECO II-16154 16-Panel Drug Test Cup is a self-contained
secure construction designed for professional screening environments
* For Forensic Use Only
Results are easy to interpret directly on the dip card in approximately 5 minutes
Single-panel screening for ETG (ethyl glucuronide)
making it ideal for high-throughput or time-sensitive screening environments where rapid synthetic cannabinoid detection is required
sealed cup design helps reduce handling steps and user error• Specimen validity/adulteration checks (configuration dependent) to support sample integrity and reduce tampering risk
